2 completed, 1 active not recruiting, 1 terminated, 1 unknown. 5 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Active not recruiting 1, Terminated 1, Unknown 1 |
| Phase 1 | 4 | Completed 2, Terminated 1, Unknown 1 |
Follow Amorphical Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Safety and Efficacy of AMOR-1 as a Treatment for Hypocalcemia Associated With Hypoparathyroidism in Adults AMOR-1, Crystalline Calcium Carbonate - Hypoparathyroidism | Phase 2 | Active not recruiting | Amorphical Ltd. | 62 | 2024-12-15 | 2026-08-14 |
| Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients. AMOR 18 Powder & Inhalation, Placebo - Covid19 | Phase 1 / Phase 2 | Completed | Amorphical Ltd. | 66 | 2021-02-09 | 2024-02-28 |
| A Study Comparing the Effect of Amorphous Calcium Carbonate (ACC) on Healing Time of Distal Radius Fractures Amorphous calcium carbonate, Placebo - Distal Radius Fractures | Phase 1 / Phase 2 | Terminated | Amorphical Ltd. | 15 | 2013-06-01 | 2016-08-04 |
| A Study Comparing Amorphous Calcium Carbonate (ACC) Versus Crystalline Calcium CCS) in Hypoparathyroidism Patients amorphous calcium carbonate, crystalline calcium supplements - Hypoparathyroidism | Phase 1 / Phase 2 | Completed | Amorphical Ltd. | 10 | 2013-04-01 | 2015-03-31 |
| Amorphous Calcium Carbonate (Acc) Versus Crystalline Calcium Carbonate (Ccc) Using Stable Calcium Isotopes In Postmenopausal Women CCC, ACC - Postmenopause | Phase 1 / Phase 2 | Unknown | Tel-Aviv Sourasky Medical Center | 15 | 2011-05-01 | 2011-04-19 |
Hypoparathyroidism (2) · COVID-19 (1) · Hypocalcemia (1) · Wrist Fractures (1)
Inhalation (1)
Israel (5)
Einat Dekel, DVM (2) · Ilan Shimon, MD (1) · Omri Lubovsky, MD (1) · Sophia Ish-Shalom, MD (1)